-
Covaxin: Twitterati spill anger over Bharat Biotech’s Covaxin pricing
Majority of the Indian twitter users have expressed their anger on social media over variation in the costs of vaccine set for people.
-
Covaxin price in India: Rs 600/dose to state governments, Rs 1,200/dose to private hospitals
"We would like to state that more than 50% of our capacities have been reserved for central government supplies," said Krishna M Ella, Bharat Biotec
-
Covid-19 vaccine: Centre’s flexible pricing policy will harm the public; earn producers super profits
By leaving the poor to the mercy of impecunious or uncaring state governments and profit-maximising private hospitals, the Centre has failed to live u
-
Money9 Edit | Shrug off vaccine scepticism to overcome pandemic-led woes
While it is clear that there is no room for complacency, there is also perhaps no need to panic. In times of pestilence, panic mongering turns into a
-
ICMR says Covaxin fights double-mutant, which vaccine should you take?
Vaccine is supposed to build immunity in your body, to strengthen the immune system against foreign invaders. Infection can occur even after vaccinati
-
Covaxin demonstrates 78% efficacy in Phase-3 interim analysis
The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 10% over the age of 60, with analysis conducted 14 days post-seco
-
Covaxin neutralises double mutant strain: ICMR
Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe
-
Covishield comprises over 90% of 12.76 crore COVID vaccines administered so far
Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more
-
Money9 Edit | Vaccination drive: Strengthen the free window, but let others pay
The government has decided to ‘open up’ the market of COVID-19 vaccines in the country and the natural step is to allow some consumers pay for the
-
COVID-19 vaccines: From status to approvals, all your questions answered
Let's take a look at other vaccine candidates that India can consider to expand the basket of jabs for domestic use
